Rowpar Pharmaceuticals said that an in vitro laboratory analysis found that its CloSys ultrasensitive oral rinse reduced SARS-CoV-2 by up to 98.4% within 30 seconds. The study was conducted at an ...
CloSYS launched its new preflavored, alcohol-free oral healthcare rinse at the 2015 Chicago Midwinter Meeting. Offered at the same cost as the company's original unflavored rinse, the new JustRight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback